Protalix BioTherapeutics to Present at Two Upcoming

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences

CARMIEL, Israel, May 28, 2014 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE: PLX ), today announced that senior management will present at the Jefferies 2014 Global Healthcare Conference and the Wells Fargo Securities Research & Economics 2014 Healthcare Conference. Details regarding the conferences are as follows:

Jefferies 2014 Global Healthcare Conference
Monday, June 2, 2014 at 4:00 PM ET
The Grand Hyatt, New York, NY
 
Wells Fargo Securities Research & Economics 2014 Healthcare Conference
Tuesday, June 17, 2014 at 2:55 PM ET
The Boston Intercontinental Hotel, Boston, MA

A live webcast of each presentation will be available at www.protalix.com on the event calendar page and a replay of each conference will be archived and available after the respective conference for 30 days.

About Protalix BioTherapeutics, Inc.

Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx ® . Protalix's unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012, by Israel's Ministry of Health in September 2012, by the Brazilian National Health Surveillance Agency (ANVISA) in March 2013, by the Mexican Federal Commission for the Protection against Sanitary Risk (COFEPRIS) in April 2013, by the Australian Therapeutic Goods Administration (TGA) in May 2014 and by the regulatory authorities of other countries. Marketing applications for taliglucerase alfa have been filed in additional territories as well. Protalix has partnered with Pfizer Inc. for the worldwide development and commercialization of taliglucerase alfa, excluding Israel and Brazil, where Protalix retains full rights. Protalix's development pipeline includes the following product candidates: PRX-102, a modified version of the recombinant human alpha-GAL-A protein for the treatment of Fabry disease; PRX-112, an orally-delivered glucocerebrosidase enzyme that is produced and encapsulated within carrot cells, also for the treatment of Gaucher disease; pr-antiTNF, a similar plant cell version of etanercept (Enbrel ® ) for the treatment of certain immune and inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, colitis, psoriasis and other autoimmune and inflammatory disorders; PRX-110 for the treatment of Cystic Fibrosis; and others.

Investor Contact Tricia Truehart The Trout Group, LLC 646-378-2953 Media Contact Kari Watson MacDougall Biomedical Communications 781-235-3060

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR Investors Face Action: Nov. 20 Deadline Nears

Updated Category News Views 77

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Continue Reading
Worker.ai Acquires DeltaGen to Spice Up SMB Growth

Updated Category News Views 144

Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...

Continue Reading
Walmart Tops 2026 Recall List: 81 Notices, Food Issues Lead

Updated Category News Views 72

Walmart Behind 81 Recalls: Scrutinizing 2026's Top Contender For an outfit that prides itself on shaking up shopping carts coast to coast, Walmart's stumble onto the recall hotseat this year is a head-scratcher. Imagine leading with 81 official recalls—that's more than a flash in the pan, it's the whole frying pan catching fire. Target and Costco aren't slouches, but...

Continue Reading
Borr Drilling Preps for Q3 2026 Financial Results Call

Updated Category News Views 95

Anticipation Builds for Borr Drilling's Q3 Reveal Sit tight, investors. Borr Drilling Limited is set to drop its Q3 2026 financial results soon—right in the sweet spot post-market close on November 18. These moments are where fortunes are made or broken, and Borr's gearheads better be ready to spill the beans on how their offshore ventures fared in the rocky sea of...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 136

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 91

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 86

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ani Huang: NAHR Fellow Elevates HR Leadership Standards

Updated Category News Views 177

Spotlight on Ani Huang's HR Leadership In a world where corporate strategies and workforce dynamics continually evolve, Ani Huang's ascent to Fellow of the National Academy of Human Resources (NAHR) signals a pivotal recognition. It's not just another pat on the back; it's a validation of a career steered by determination, expertise, and a knack for navigating the tangled...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 145

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 120

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading

Top 5 Most Recently Viewed Articles

Visage Showcases AI-Driven Imaging Solutions at Major Event

Updated Category News Views 170

Visage Introduces Innovations in AI Enhanced Imaging Visage Imaging, Inc. is set to unveil several cutting-edge advancements at the upcoming RSNA 2025 annual meeting. Known for their industry-leading Visage 7 | CloudPACS, the company aims to enhance enterprise imaging with powerful AI tools designed specifically for today's demands in the healthcare sector. Understanding...

Continue Reading
Madison Liquidators Expands Office Solutions with Floortex Mats

Updated Category News Views 82

Madison Liquidators Expands Office Solutions with Floortex Mats Madison Liquidators has made exciting additions to their office furniture lineup by introducing new office chair mats from the well-regarded brand partner, Floortex. These mats play a vital role in enhancing the user experience within various workspaces. Designed to protect flooring while supporting ergonomic...

Continue Reading
Clarivate Sells LS&H Segment, Refocuses on Growth

Updated Category News Views 33

When you're running a business, sometimes you've got to cut off a leg to save the rest. And that's just what Clarivate's done, shoveling their Life Sciences & Healthcare segment off to Altaris LLC for a cool $600 million. Now, this ain't just to jazz up the books—it's about reshaping the future. They're slicing and dicing to laser-beam their focus on Academia &...

Continue Reading
Alecta Enhances Trading Efficiency Using FlexTRADER EMS Solution

Updated Category News Views 96

Alecta Transitions to FlexTRADER EMS for Enhanced Trading Alecta, one of Europe’s largest occupational pension companies, has recently optimized its cross-asset trading by adopting FlexTRADER EMS, a powerful execution management system provided by FlexTrade Systems. This new system is designed specifically to enhance Alecta's capabilities in equities and derivatives...

Continue Reading
Crescent Capital Finance Drives Acquisition of Governance Group

Updated Category News Views 109

Crescent Capital Group's Role in Financing Crescent Capital Group LP, a prominent name in alternative credit investment, has recently taken a significant step by leading the financing for the acquisition of Independent Governance Group (IGG). This acquisition is a joint venture with ECI Partners, a mid-market private equity firm based in the UK. The partnership aims to...

Continue Reading